Peni-Kel 300000 IU/ml Suspension injectable
Peni-Kel 300000 IU/ml Suspension injectable
Authorised
- Benzylpenicillin procaine
Product identification
Medicine name:
Peni-Kel 300000 IU/ml Suspension injectable
Active substance:
- Benzylpenicillin procaine
Target species:
-
Cattle
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Benzylpenicillin procaine300.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal9day
-
Milk8day
-
-
Pig
-
Meat and offal5day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Peni-Kel 300000 IU/ml Suspension for injection 1 vial of 30 ml
- Peni-Kel 300000 IU/ml Suspension for injection 1 vial of 50 ml
- Peni-Kel 300000 IU/ml Suspension for injection 1 vial of 100 ml
- Peni-Kel 300000 IU/ml Suspension for injection 1 vial of 250 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 188/18/05/1692
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/03/2023
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/03/2023